NDC 49520-101-11 - OBLITERATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49520-101
- Requested NDC
- 49520-101-11
- Package NDCs from labels
- 49520-101-11, 49520-101-51
- Manufacturer
- mybody
- Effective date
- 2012-05-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OBLITERATE - mybody | mybody | 2012-05-02 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49520-101-51 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d1b4-f6ea-e053-dbdaa90aa703 | OBLITERATE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49520-101-11 | OBLITERATE | 15 mL in 1 BOTTLE | LOTION | 15 | 7 | |
| 49520-101-51 | OBLITERATE | 1 in 1 BOX | LOTION | 1 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erythromycin and Benzoyl Peroxide | ERYTHROMYCIN AND BENZOYL PEROXIDE | Rising Pharma Holdings, Inc. | d449d7e2-5c25-406d-87ab-30809d292476 | 2025-09-05 | Warnings, Adverse reactions | W9WZN9A0GM |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Encube Ethicals, Inc. | 8ca01174-431e-449a-a85e-8c68d506776c | 2025-08-29 | Warnings, Adverse reactions | W9WZN9A0GM |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Oceanside Pharmaceuticals | 1d53ec2b-d33d-4245-99f1-e41b30303660 | 2025-08-15 | Warnings, Adverse reactions | W9WZN9A0GM |
| Twyneo | BENZOYL PEROXIDE AND TRETINOIN | Mayne Pharma Commercial LLC | 654ae869-5bc0-40b3-a423-dcc3270c05d8 | 2025-08-11 | Warnings, Adverse reactions | W9WZN9A0GM |
| Epsolay | BENZOYL PEROXIDE | Mayne Pharma Commercial LLC | 641981e6-460b-44dd-8146-306c47e5367c | 2025-08-11 | Warnings, Adverse reactions | W9WZN9A0GM |
| ONEXTON | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bausch Health US, LLC | 697e760a-c206-4565-8f4e-a8085e215827 | 2025-07-23 | Warnings, Adverse reactions | W9WZN9A0GM |
| La Roche Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Medication Cleanser | BENZOYL PEROXIDE | L'Oreal USA Products Inc | cf49ed9b-8c1d-49f9-8c77-bb6a5abce9e4 | 2025-07-09 | Warnings | W9WZN9A0GM |
| Neutrogena Clear Pore Cleanser Mask | BENZOYL PEROXIDE | Kenvue Brands LLC | d020adb5-7f87-42c0-939d-99eb8744f65e | 2025-07-07 | Warnings | W9WZN9A0GM |
| ADAPALENE and BENZOYL PEROXIDE | ADAPALENE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | a53f1aa5-d3d1-45af-8728-8f36090f49da | 2025-07-03 | Warnings, Adverse reactions | W9WZN9A0GM |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | b39aaacb-f429-4cb4-b88b-341b8b8b217c | 2025-07-03 | Warnings, Adverse reactions | W9WZN9A0GM |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | 0a98fc1e-be75-4c22-a7a7-2e4f033b3701 | 2025-07-03 | Warnings, Adverse reactions | W9WZN9A0GM |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | 449884c1-cf3b-4e2c-b8a0-82442ea8523a | 2025-07-03 | Warnings, Adverse reactions | W9WZN9A0GM |
| Adapalene and Benzoyl Peroxide | ADAPALENE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | 13fc72e9-7178-4a8b-9fe8-d88ba591dac8 | 2025-07-02 | Warnings, Adverse reactions | W9WZN9A0GM |
| Adapalene and benzoyl peroxide | ADAPALENE AND BENZOYL PEROXIDE | Zydus Lifesciences Limited | d374a9b9-3ee9-4bc4-bcb9-a947d76cb6e5 | 2025-06-13 | W9WZN9A0GM | |
| Adapalene and benzoyl peroxide | ADAPALENE AND BENZOYL PEROXIDE | Viona Pharmaceuticals Inc | 3a0fa489-4720-4760-a476-2317aef5a231 | 2025-06-13 | Warnings, Adverse reactions | W9WZN9A0GM |
| Neutrogena Stubborn Acne AM Treatment | BENZOYL PEROXIDE | Kenvue Brands LLC | d6e05b11-8c5f-490d-a5d8-116dcc895cb8 | 2025-06-04 | Warnings | W9WZN9A0GM |
| ADAPALENE AND BENZOYL PEROXIDE | ADAPALENE AND BENZOYL PEROXIDE TOPICAL | Alembic Pharmaceuticals Limited | 2d4e5111-4f9f-42dd-8cf7-56bdc51fbbad | 2025-05-27 | Warnings, Adverse reactions | W9WZN9A0GM |
| ADAPALENE AND BENZOYL PEROXIDE | ADAPALENE AND BENZOYL PEROXIDE TOPICAL | Alembic Pharmaceuticals Inc. | 73a32997-23da-46b6-8652-7197f55c9847 | 2025-05-21 | Warnings, Adverse reactions | W9WZN9A0GM |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Neutrogena On-the-Spot Acne Treatment Vanishing Formula | BENZOYL PEROXIDE | Kenvue Brands LLC | 7cc8f53d-b8e3-4711-a1d3-fd43be35af51 | 2025-05-12 | Warnings | W9WZN9A0GM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.